Beth Israel Medical Center BIMC

New York, New York 10003

0 studies enrolling now · 1 studies all time

What they study most

HER2+ Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer — Stopped early